SecBot SecBot
8-K/A ·Filed Oct 20, 2026

ASBP

Aspire-Lakewood Holdings, Inc.
MIXED
Impact 7/10
Horizonmonths Processed7d 9h ago SEC0001493152-26-047801
8-K with no item list reported
Actionable Insight ◆ Mixed

The acquisition fundamentally changes ASBP's business profile from a pre-revenue biopharma to an automotive supplier with ~$209M in revenue. Monitor integration execution, the final purchase price allocation (especially intangible asset values and goodwill/bargain purchase), and the Lakewood put option's impact on future equity. The company's ability to service the new Axos debt and manage DCS's declining profitability (net loss in H1 2026) will be key.

DirectionMixed
Confidencehigh
Horizonmonths
Latest settled — T+1d
ASBP ▲ +0.56% at T+1d
NEUTRAL call +0.56% · α vs SPY +1.75% · entry $8.85 → $8.90
Next anchor: T+5d due 19h ago
Latest observation: T+3 +4.38% FF3 residual α
Entry = T+0 close
Oct 20, 2026
via day close
T+1d
+0.56%
call +0.56% · α +1.75%
$8.90
settled 7d ago
T+5d
Pending
due 19h ago
T+20d
Pending
in 20d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Aspire-Lakewood Holdings, Inc. (ASBP) acquired Dura Driver Control Systems (DCS) for approximately $30 million in cash on August 6, 2026, funded by existing cash and a new Axos Bank credit facility. The acquisition transforms ASBP from a pre-revenue biopharma company into an automotive mobility systems supplier with $208.9 million in pro forma 2025 revenue. A bargain purchase gain of $37.1 million was recognized, and the company entered into a five-year management services agreement with Lakewood Capital, which received a 15% equity stake in DCS and a put option.

Key Facts

  • Acquisition of DCS closed on August 6, 2026 for approximately $30 million in cash.
  • Purchase price funded by $8.8 million cash and $21.9 million from Axos Bank Credit Facility.
  • Pro forma 2025 revenue of $208.9 million vs. ASBP's standalone revenue of $6,000.
  • Pro forma 2025 net income attributable to ASBP of $11.2 million vs. ASBP standalone net loss of $24.5 million.
  • Preliminary bargain purchase gain of $37.1 million recognized.
  • Lakewood Capital received 15% equity in DCS (est. $4.5 million) and a staggered put option.
  • Management Services Agreement with Lakewood Capital: $500k closing fee, annual fee up to $1.0 million (5% of Adjusted EBITDA), 5-year term.
  • DCS FY2025 revenue $208.9M, net income $9.8M; H1 2026 revenue $103.8M, net loss $0.7M.
  • DCS had $11.0M cash, $27.1M trade receivables, $20.5M inventory, $12.4M debt as of June 30, 2026.
  • ASBP common stock and warrants trade on Nasdaq under ASBP and ASBPW.

Financial Impact

Pro forma 2025 revenue of $208.9 million vs. ASBP standalone $6,000; pro forma 2025 net income of $11.2 million vs. ASBP standalone net loss of $24.5 million; bargain purchase gain of $37.1 million; acquisition price ~$30 million cash.

revenuenet incomedebtdilutionassets

Risk Factors

  • DCS's H1 2026 net loss of $0.7M vs. H1 2025 net income of $12.2M shows deteriorating profitability.
  • DCS had negative operating cash flow of $22.3M in H1 2026 and relies on parent contributions for working capital.
  • Preliminary purchase accounting subject to material revision; bargain purchase gain may change.
  • Lakewood's 15% equity stake and put option create potential future dilution and liability.
  • Significant foreign currency exposure (DCS operates in Europe, Asia, Mexico).
  • Customer concentration: top 3 customers represent ~55% of DCS revenue.
  • Unionized workforce (38% of U.S. employees) with contracts expiring in 2027.
  • Company transitioned from biopharma to automotive — sector expertise risk.

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
8-K/A Filing (Primary)0001493152-26-047801
Exhibit: ex99-2.htm0001493152-26-047801
Exhibit: ex99-3.htm0001493152-26-047801
Exhibit: ex10-1.htm0001493152-26-047801
Document: form8-ka.htm0001493152-26-047801
Document: 0001493152-26-047801-index-headers.html0001493152-26-047801
Document: 0001493152-26-047801-index.html0001493152-26-047801
Document: 0001493152-26-047801.txt0001493152-26-047801
5 reports for ASBP
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ASBP — sortable, filterable
TypeNow
Oct 20, 2026
7d ago
8-K/A
MIXED ★ 7/10
$8.85awaiting T+20—$8.44 (−4.63%)
Aug 19, 2026
9w ago
8-K
NEUTRAL ★ 2/10
$7.90 $9.12▲ +15.44%▲ +17.39%$8.44 (+6.84%)
Aug 10, 2026
11w ago
8-K
BULLISH ★ 7/10
$7.79 $8.85▲ +13.61%▲ +14.52%$8.44 (+8.34%)
Jul 20, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$7.54 $7.64▲ +1.33%▼ −1.24%$8.44 (+11.94%)
Jun 12, 2026
19w ago
8-K
BULLISH ★ 8/10
$4.96 $6.01▲ +21.17%▲ +19.39%$8.44 (+70.16%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 6h 25m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 20, 2026